Itron Inspire 2024 to Gather Leaders to Address Industry Challenges Leveraging Data and Artificial Intelligence
July 17, 2024 08:45 ET
|
Itron, Inc.
Itron Inspire, will take place Oct. 4-10, 2024, at the JW Marriott Desert Springs Resort & Spa in Palm Desert, California.
Alterity Therapeutics Reports Positive Interim Data from ATH434-202 Phase 2 Clinical Trial in Multiple System Atrophy
July 17, 2024 07:35 ET
|
ALTERITY THERAPEUTICS LIMITED
– 43% of Participants Showed Improvement on the UMSARS Activities of Daily Living Scale – – 29% of Participants had Stable or Improved Neurological Symptoms – – Objective Biomarkers...
TransUnion Named One of Seramount’s 100 Best Companies in 2024
July 16, 2024 09:10 ET
|
TransUnion
CHICAGO, July 16, 2024 (GLOBE NEWSWIRE) -- TransUnion (NYSE: TRU) announced today it has been named one of the 100 Best Companies in 2024 by Seramount, a strategic professional services and research...
L'AIAC et ISDE publient le plus récent rapport sur l'état de l'industrie aérospatiale canadienne
July 11, 2024 14:00 ET
|
L'Association des industries aérospatiales du Canada
OTTAWA, 11 juill. 2024 (GLOBE NEWSWIRE) -- Des données récemment publiées révèlent que l'industrie aérospatiale canadienne montre des signes de reprise économique et continue d'être un moteur...
AIAC & ISED Release Latest State Of Canada’s Aerospace Industry Report
July 11, 2024 14:00 ET
|
Aerospace Industries Association of Canada (AIAC)
Aerospace Industries Association of Canada, in partnership with ISED, release the latest State of Canada’s Aerospace Industry Report.
Metrc Extends Track-and-Trace Partnership Through New Contract with State of California
July 10, 2024 11:00 ET
|
Metrc LLC
LAKELAND, Fla., July 10, 2024 (GLOBE NEWSWIRE) -- Metrc announced its new contract with the State of California, retaining its role as the state's track-and-trace software provider. “California...
OKYO Pharma Announces Promising Categorical Data from OK-101 Phase 2 Trial in Dry Eye Disease
July 10, 2024 07:00 ET
|
OKYO Pharma LTD
Encouraging 68% improvement in responder rate results from patients who achieved both the conjunctival staining “sign” and ocular pain “symptom” endpoints from the 240 patient Phase 2 Dry Eye Disease...
AI Pioneer Intent IQ Boosts Advertising Campaign Performance for Involved Media With Cookieless Alternative ID and Activation Suite
July 09, 2024 12:30 ET
|
Intent IQ
NEW YORK, July 09, 2024 (GLOBE NEWSWIRE) -- Intent IQ, a privacy-forward next-generation identity resolution leader, today announced the results of a new partnership with Involved Media, a global...
HNL Lab Medicine Enhances Emergency Care with Onboard Blood Transfusions
July 02, 2024 15:56 ET
|
Health Network Laboratories (HNL Lab Medicine)
ALLENTOWN, Pa., July 02, 2024 (GLOBE NEWSWIRE) -- HNL Lab Medicine has partnered with Lehigh Valley Health Network (LVHN) to significantly improve emergency medical care. Effective immediately, the...
Jenna Kinsman Joins EagleView; Focus on Scaling Insurance Business
July 02, 2024 09:00 ET
|
EagleView Technologies
Rochester, NY, July 02, 2024 (GLOBE NEWSWIRE) -- EagleView announces the hire of Jenna Kinsman as Vice President of Enterprise Growth for their insurance business effective June 2024. Kinsman comes...